4.7 Article

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

Jeroen J. A. van Kampen et al.

Summary: The study found that the median duration of shedding infectious virus in COVID-19 patients is 8 days, dropping below 5% after 15.2 days post onset of symptoms. High viral loads are associated with infectious SARS-CoV-2 isolation, while high serum neutralizing antibody titres are associated with non-infectious SARS-CoV-2.

NATURE COMMUNICATIONS (2021)

Article Infectious Diseases

Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs

Paolo Calistri et al.

Summary: A targeted surveillance in the Abruzzo region of Italy detected 313 persons affected by lineage B.1.1.7, with statistically significant differences in viral load and persistence compared to other lineages. In individuals infected with B.1.1.7 lineage, lower values of C-T associated with the detection of the N protein encoding gene and longer persistence of SARS-CoV-2 RNA in nasopharyngeal swabs were observed.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Immunology

S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction

Michael Kidd et al.

Summary: Analysis of recent test data shows that samples containing the SARS-CoV-2 variant B1.1.7 with mutation Delta 69/70 exhibit S gene target failure (SGTF) in ThermoFisher TaqPath RT-qPCR. Samples with SGTF profile are more likely to have higher viral loads, indicating higher infectivity and rapid spread of this variant.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Dami A. Collier et al.

Summary: The B.1.1.7 variant of SARS-CoV-2 exhibited reduced neutralization by vaccines and antibodies from recovered COVID-19 patients, with a more substantial loss seen when introducing the E484K mutation. This mutation poses a threat to the efficacy of the BNT162b2 vaccine.

NATURE (2021)

Article Multidisciplinary Sciences

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Nicholas G. Davies et al.

Summary: A new variant of SARS-CoV-2 has emerged in England, with a higher reproduction number and potential for large resurgences of COVID-19 cases. Without stringent control measures, it is projected that COVID-19 hospitalizations and deaths in England for the first 6 months of 2021 will exceed those in 2020. The variant has spread globally and exhibited similar transmission increases in Denmark, Switzerland, and the United States.

SCIENCE (2021)

Article Infectious Diseases

SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020

Arnaud Fontanet et al.

Summary: The study conducted in schools in northern France suggests that children may play an important role in the transmission of SARS-CoV-2, with viral circulation identified in many schools. Enhanced control measures and surveillance in schools are needed to reduce the risk of transmission.

EUROSURVEILLANCE (2021)

Article Infectious Diseases

Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study

Dan Frampton et al.

Summary: This study describes the emergence of the B.1.1.7 variant of concern, its virological characteristics, and clinical severity in patients. Increased viral load was found in B.1.1.7 infection, but no association with severe disease was identified in the hospitalized cohort.

LANCET INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7

Nicholas G. Davies et al.

Summary: Studies have shown that the SARS-CoV-2 B.1.1.7 lineage is more transmissible and may cause more severe illness compared to pre-existing variants.

NATURE (2021)

Article Biochemistry & Molecular Biology

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

Delphine Planas et al.

Summary: The ability of convalescent sera from individuals with coronavirus disease 2019 and those vaccinated with BNT162b2 to neutralize SARS-CoV-2 variants B1.1.7 and B.1.351 decreases, but increases after two vaccine doses. The study found that the B.1.1.7 and B.1.351 variants may have acquired partial resistance to neutralizing antibodies generated by natural infection or vaccination, particularly in individuals with low antibody levels. This suggests that the B.1.351 variant may pose a greater risk of infection in immunized individuals.

NATURE MEDICINE (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 infection of the oral cavity and saliva

Ni Huang et al.

Summary: The study highlights the potential role of the oral cavity in COVID-19 pathogenesis, with evidence of SARS-CoV-2 infection and transmission via saliva. Viral shedding dynamics in saliva correlated with symptoms, and asymptomatic individuals were found to harbor sustained salivary antibodies against SARS-CoV-2 post-recovery.

NATURE MEDICINE (2021)

Article Multidisciplinary Sciences

Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities

Qing Yang et al.

Summary: The study found that even asymptomatic individuals with SARS-CoV-2 may have low viral loads that are not infectious. Moreover, only 2% of individuals are responsible for carrying 90% of the virions circulating within communities, potentially acting as viral supercarriers and superspreaders.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Infectious Diseases

Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses

Hedvig Glans et al.

Summary: Our study at Karolinska University Hospital investigated the timeframe and potential risk of SARS-CoV-2 transmission from hospitalized COVID-19 patients in relation to antibody response. The results suggest that the presence of SARS-CoV-2 specific antibodies in serum may indicate a lower risk of shedding infectious SARS-CoV-2 by hospitalized COVID-19 patients.

BMC INFECTIOUS DISEASES (2021)

Article Virology

Performance of six rapid diagnostic tests for SARS-CoV-2 antigen detection and implications for practical use

Slim Fourati et al.

Summary: The study evaluated the sensitivity and specificity of 6 SARS-CoV-2 antigen rapid diagnostic tests, showing that these tests are easy to conduct and their sensitivity and specificity depend on the delay of sampling and viral load.

JOURNAL OF CLINICAL VIROLOGY (2021)

Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

Article Immunology

Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection

Nikaia Smith et al.

Summary: This study conducted a paired analysis of nasopharyngeal and systemic immune responses in COVID-19 patients, revealing distinct compartmentalization of immunity and shifts in the microbiome.

NATURE IMMUNOLOGY (2021)

Article Medicine, General & Internal

Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters

Rana Abdelnabi et al.

Summary: The global COVID-19 pandemic has resulted in over 108 million infections and 2.4 million deaths within a year, with new variants of concern emerging. Research on prototypic VoC from B.1.1.7 and B.1.351 variants in hamsters revealed efficient infection of the lower respiratory tract and highlighted the need for assessing vaccine and therapeutic efficacy against these variants.

EBIOMEDICINE (2021)

Review Critical Care Medicine

Emerging SARS-CoV-2 variants of concern and potential intervention approaches

Jasmin Khateeb et al.

Summary: Mutations in VOCs can increase the transmissibility of the virus and potentially impact vaccine efficacy, highlighting the need for combination therapeutic strategies.

CRITICAL CARE (2021)

Review Infectious Diseases

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis

Muge Cevik et al.

Summary: This study aimed to characterize the viral load dynamics, duration of viral shedding, and viable virus shedding of SARS-CoV-2 in various body fluids. The findings suggest that while SARS-CoV-2 RNA shedding can be prolonged in respiratory and stool samples, the duration of viable virus shedding is relatively short-lived.

LANCET MICROBE (2021)

Article Immunology

Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples

Jared Bullard et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

Virological assessment of hospitalized patients with COVID-2019

Roman Woelfel et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Temporal dynamics in viral shedding and transmissibility of COVID-19

Xi He et al.

NATURE MEDICINE (2020)

Article Medicine, General & Internal

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

M. M. Arons et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Infectious Diseases

Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards

Bernard La Scola et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Carolina Lucas et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Syncytia formation by SARS-CoV-2-infected cells

Julian Buchrieser et al.

EMBO JOURNAL (2020)

Review Infectious Diseases

SARS-CoV-2 detection, viral load and infectivity over the course of an infection

Kieran A. Walsh et al.

JOURNAL OF INFECTION (2020)

Article Biochemistry & Molecular Biology

Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong

Dillon C. Adam et al.

NATURE MEDICINE (2020)

Editorial Material Medicine, General & Internal

Asymptomatic transmission of covid-19

Allyson M. Pollock et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Multidisciplinary Sciences

IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise

Julian Buchrieser et al.

SCIENCE (2019)

Article Multidisciplinary Sciences

Type I interferon-mediated autoinflammation due to DNase II deficiency

Mathieu P. Rodero et al.

NATURE COMMUNICATIONS (2017)